ISSN print edition: 0366-6352
ISSN electronic edition: 1336-9075
Registr. No.: MK SR 9/7

Published monthly
 

An improved route to urapidil from 1-(2-methoxyphenyl)piperazine and oxetane

Li-Zhi Zhang, Feng-Liang Liu, Hao-Yue Xiang, Zhen-Yu Zhan, and Jie Shen

College of Chemistry and Chemical Engineering, Central South University, Changsha, China

 

E-mail: lflcsu@csu.edu.cn

Received: 31 October 2023  Accepted: 3 March 2024

Abstract:

Urapidil is an important drug for the treatment of essential hypertension and intravenously in hypertensive emergencies. Herein, an improved route to Urapidil was introduced. The new designed synthetic route starts with the addition reaction of 1-(2-methoxyphenyl)piperazine and oxetane catalyzed by Yb(OTf)3 in acetonitrile to form the key intermediate 3-(4-(2-methoxyphenyl)piperazin-1-yl)propan-1-ol. Additionally, 3-(4-(2-methoxyphenyl)piperazin-1-yl)propan-1-ol was purified by recrystallization from the optimized solvents, which was beneficial to large scale production. Intermediate 3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl-4-methylbenzenesulfonate was cast directly for the subsequent reaction without further purification. The overall yield of this route is about 45%. The structure of the final product was well confirmed by 1H-NMR, 13C-NMR and HRMS.

Keywords: Urapidil; 1-(2-methoxyphenyl)piperazine; Oxetane; Yb(OTf)3; Catalysis

Full paper is available at www.springerlink.com.

DOI: 10.1007/s11696-024-03398-2

 

Chemical Papers 78 (7) 4395–4400 (2024)

Saturday, June 15, 2024

IMPACT FACTOR 2021
2.146
SCImago Journal Rank 2021
0.365
SEARCH
Advanced
VOLUMES
European Symposium on Analytical Spectrometry ESAS 2022
© 2024 Chemical Papers